Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco

Updated on: April 01,2024 16

Breast cancer recurrence rate not up with autologous fat transfer

(HealthDay)—For patients with breast cancer, reconstruction with autologous fat transfer (AFT) seems not to increase the rate of locoregional recurrence versus conventional breast reconstruction, acco

Updated on:April 01,2024 16

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024 14

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024 14

Artificial DNA kills cancer: Hairpin-shaped DNA binds with microRNA in cancer cells to trigger an immune response

byUniversity of TokyoOncolytic DNA hairpin pairs (oHPs) are introduced to the cancer cell. When the oHPs encounter the tumor-causing overexpressed microRNA (miRNA), they unravel to connect with

Updated on: January 02,2024 8

Artificial DNA kills cancer: Hairpin-shaped DNA binds with microRNA in cancer cells to trigger an immune response

byUniversity of TokyoOncolytic DNA hairpin pairs (oHPs) are introduced to the cancer cell. When the oHPs encounter the tumor-causing overexpressed microRNA (miRNA), they unravel to connect with

Updated on:January 02,2024 8

Myths about PSA tests and prostate cancer screening

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: Unsplash/CC0 Public DomainThe understanding of prostate cancer has significantly evolved in the past 15 years. However, many people

Updated on: April 28,2024 0

Myths about PSA tests and prostate cancer screening

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: Unsplash/CC0 Public DomainThe understanding of prostate cancer has significantly evolved in the past 15 years. However, many people

Updated on:April 28,2024 0

Combination of photonic sensors and microfluidics could detect cancer markers within 20 minutes

by Andrei Korshunov,Skolkovo Institute of Science and TechnologyStudy co-author and Skoltech PhD student Aleksei Kuzin posing next to a measurement stand. He is holding thephotonic chip th

Updated on: March 05,2024 19

Combination of photonic sensors and microfluidics could detect cancer markers within 20 minutes

by Andrei Korshunov,Skolkovo Institute of Science and TechnologyStudy co-author and Skoltech PhD student Aleksei Kuzin posing next to a measurement stand. He is holding thephotonic chip th

Updated on:March 05,2024 19

Natural mechanism causes 50-fold increase in T-cell activation sensitivity

byLatrobe UniversityThymic cortical T cell deletion induced by a CDR3 cysteine. TCR-retrogenic mice expressing the 6218 or 6218αC TCR were made as described in Fig.1, except that all recip

Updated on: January 22,2024 18

Natural mechanism causes 50-fold increase in T-cell activation sensitivity

byLatrobe UniversityThymic cortical T cell deletion induced by a CDR3 cysteine. TCR-retrogenic mice expressing the 6218 or 6218αC TCR were made as described in Fig.1, except that all recip

Updated on:January 22,2024 18

Adhering to global health recommendations reduces cancer risk

byNewcastle UniversityCredit: CC0 Public DomainPeople who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms

Updated on: January 22,2024 17

Adhering to global health recommendations reduces cancer risk

byNewcastle UniversityCredit: CC0 Public DomainPeople who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms

Updated on:January 22,2024 17

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on: March 30,2024 17

BRAF inhibitor shows promising results in pediatric patients with low-grade glioma

by American Association for Cancer ResearchGlioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0Dabrafenib (Tafinlar), a BRAF inhibitor approve

Updated on:March 30,2024 17

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on: June 28,2024 3

Study identifies new potential treatment option for triple negative breast cancer

by Mayo ClinicCredit: Mayo ClinicIn a recent study published in theJournal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndro

Updated on:June 28,2024 3

Genetically modified virus combats prostate cancer

by FAPESPIn a study with mice, a gene therapy developed in Brazil kills cancer cells and avoids adverse side effects when combined with chemotherapy. Credit: Marcos Santos / USP ImagensResearcher

Updated on: April 01,2024 19

Genetically modified virus combats prostate cancer

by FAPESPIn a study with mice, a gene therapy developed in Brazil kills cancer cells and avoids adverse side effects when combined with chemotherapy. Credit: Marcos Santos / USP ImagensResearcher

Updated on:April 01,2024 19

Direct-acting antivirals still underused in hep C-related liver cancer

by Lori SolomonDirect-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver M

Updated on: April 10,2024 12

Direct-acting antivirals still underused in hep C-related liver cancer

by Lori SolomonDirect-acting antiviral agents (DAAs) remain underutilized in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), according to a study presented at The Liver M

Updated on:April 10,2024 12

Unique approach to treatment of rare and aggressive blood cancers

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainA unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and dif

Updated on: April 10,2024 15

Unique approach to treatment of rare and aggressive blood cancers

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainA unique approach to targeting the abnormal T-cells that cause T-cell lymphomas could offer hope to patients with the aggressive and dif

Updated on:April 10,2024 15